AnGes
4563.TTSE GROWTHPharmaceutical
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Growth Partners Co., Ltd. | 29.74% |
| Noriatsu Furukawa | 15.39% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| Athos Capital Limited | 2.93% |
| Merrill Lynch International | 0.03% |
| Cantor Fitzgerald Europe | 0.00% |
| BofA Securities, Inc. | 0.00% |
| BofA Securities Japan Co Ltd | 0.00% |
Ownership history · 45
| Holder | Ratio | Change |
|---|---|---|
| Cantor Fitzgerald Europe2026-09-24 | 0.00% | -18.14pp |
| Noriatsu Furukawa2026-09-04 · amended | 15.39% | new |
| Growth Partners Co., Ltd.2026-09-04 · amended | 15.39% | new |
| Cantor Fitzgerald Europe2026-01-09 | 18.14% | -1.85pp |
| Cantor Fitzgerald Europe2025-12-01 | 19.99% | +19.99pp |
| Athos Capital Limited2025-08-28 | 2.93% | -3.14pp |
| Athos Capital Limited2025-08-19 | 6.07% | new |
| Cantor Fitzgerald Europe2025-08-18 | 0.00% | -6.75pp |
| Cantor Fitzgerald Europe2025-07-18 | 6.75% | -1.01pp |
| Cantor Fitzgerald Europe2025-07-01 | 7.76% | -1.10pp |
| Cantor Fitzgerald Europe2025-06-02 | 8.86% | -2.79pp |
| Cantor Fitzgerald Europe2025-05-26 | 11.65% | -1.19pp |
| Cantor Fitzgerald Europe2025-04-18 | 12.84% | -1.04pp |
| Cantor Fitzgerald Europe2025-03-24 | 13.88% | -1.03pp |
| Cantor Fitzgerald Europe2025-03-11 | 14.91% | -1.10pp |
| Cantor Fitzgerald Europe2025-03-04 | 16.01% | -1.67pp |
| Cantor Fitzgerald Europe2025-02-14 | 17.68% | -1.82pp |
| Cantor Fitzgerald Europe2025-02-06 | 19.50% | -1.44pp |
| Cantor Fitzgerald Europe2025-02-04 | 20.94% | -1.08pp |
| Cantor Fitzgerald Europe2025-01-29 | 22.02% | -1.15pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.